Official Title
French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management: the FRENCH CORONA Study
Brief Summary

Since December 2019, a new agent, the SARS-Cov-2 coronavirus has been rapidly spreading from China to other countries causing an international outbreak of respiratory illnesses named COVID-19. In France, the first cases have been reported at the end of January with more than 60000 cases reported since then. A significant proportion (20-30%) of hospitalized COVID-19 patients will be admitted to intensive care unit. However, few data are available for this special population in France. We conduct a large observational cohort of ICU suspected or proven COVID-19 patients that will enable to describe the initial management of COVID 19 patients admitted to ICU and to identify factors correlated to clinical outcome.

Recruiting
Pneumonia, Viral
Critically Ill
Corona Virus Infection

Other: No intervention
No intervention
Control
Suspected or proven COVID-19 critically ill patients

Eligibility Criteria

Inclusion Criteria:

- Patients admitted to ICU for suspected or proven SARS-Cov-2 infection, defined by positive SARS-Cov-2 PCR or CT scan images

- Patient > or= 18 years

Exclusion Criteria:

- Patient study refusal

- Patient already enrolled in the present study

- Patient with respiratory illness with negative COVID-19 CT scan images and negative COVID_19 PCR

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years
Countries
France
Contacts

CLAIRE ROGER, MD, PhD
0033466683050
claire.roger@chu-nimes.fr

Anissa MEGZARI
drc@chu-nimes.fr

CLAIRE ROGER
Principal Investigator
Nimes University Hospital

Centre Hospitalier Universitaire de Nīmes
NCT Number
Keywords
Covid-19
SARS-CoV-2
Intensive care unit
MeSH Terms
Infection
Communicable Diseases
Coronavirus Infections
Severe Acute Respiratory Syndrome
Pneumonia, Viral
Pneumonia
Critical Illness